SAN CARLOS, Calif. (AP) — SAN CARLOS, Calif. (AP) — Iovance Biotherapeutics Inc. (IOVA) on Thursday reported a loss of $78.6 million in its fourth quarter.
On a per-share basis, the San Carlos, California-based company said it had a loss of 26 cents.
The results surpassed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 27 cents per share.
The biotechnology company posted revenue of $73.7 million in the period, also beating Street forecasts. Six analysts surveyed by Zacks expected $72.1 million.
For the year, the company reported a loss of $372.2 million, or $1.28 per share. Revenue was reported as $164.1 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IOVA at https://www.zacks.com/ap/IOVA
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
